Schaller Investment Group Inc. bought a new stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) during the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor bought 152,500 shares of the pharmacy operator’s stock, valued at approximately $9,152,000. Walgreens Boots Alliance accounts for approximately 5.1% of Schaller Investment Group Inc.’s investment portfolio, making the stock its 8th largest position.
Several other institutional investors and hedge funds have also modified their holdings of WBA. Archford Capital Strategies LLC bought a new stake in shares of Walgreens Boots Alliance in the 1st quarter valued at approximately $115,000. BlueMountain Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $103,000. CSat Investment Advisory L.P. bought a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $104,000. Squar Milner Financial Services LLC bought a new stake in shares of Walgreens Boots Alliance in the 2nd quarter valued at approximately $106,000. Finally, Kaizen Advisory LLC grew its stake in shares of Walgreens Boots Alliance by 128.6% in the 2nd quarter. Kaizen Advisory LLC now owns 1,925 shares of the pharmacy operator’s stock valued at $116,000 after buying an additional 1,083 shares in the last quarter. Institutional investors own 61.98% of the company’s stock.
In other news, Director William C. Foote sold 2,736 shares of the stock in a transaction that occurred on Thursday, August 2nd. The stock was sold at an average price of $65.99, for a total value of $180,548.64. Following the completion of the sale, the director now directly owns 10,943 shares of the company’s stock, valued at $722,128.57. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, COO Ornella Barra acquired 1,700,000 shares of Walgreens Boots Alliance stock in a transaction dated Monday, July 16th. The stock was acquired at an average cost of $65.15 per share, with a total value of $110,755,000.00. The disclosure for this purchase can be found here. 14.80% of the stock is owned by corporate insiders.
Shares of Walgreens Boots Alliance stock opened at $68.92 on Monday. The company has a market cap of $67.67 billion, a price-to-earnings ratio of 13.51, a P/E/G ratio of 1.04 and a beta of 1.09. The company has a debt-to-equity ratio of 0.44, a current ratio of 0.93 and a quick ratio of 0.47. Walgreens Boots Alliance Inc has a 12-month low of $59.07 and a 12-month high of $83.89.
Walgreens Boots Alliance (NASDAQ:WBA) last announced its earnings results on Thursday, June 28th. The pharmacy operator reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.47 by $0.06. The firm had revenue of $34.33 billion during the quarter, compared to analysts’ expectations of $34.15 billion. Walgreens Boots Alliance had a return on equity of 21.22% and a net margin of 3.36%. The company’s revenue was up 14.0% on a year-over-year basis. During the same quarter in the prior year, the business earned $1.33 earnings per share. equities analysts predict that Walgreens Boots Alliance Inc will post 5.97 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Wednesday, September 12th. Shareholders of record on Monday, August 20th will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, August 17th. This represents a $1.76 dividend on an annualized basis and a yield of 2.55%. This is a boost from Walgreens Boots Alliance’s previous quarterly dividend of $0.40. Walgreens Boots Alliance’s dividend payout ratio is presently 34.51%.
Several equities research analysts recently commented on WBA shares. Cowen cut Walgreens Boots Alliance from an “outperform” rating to a “market perform” rating and set a $104.00 price target for the company. in a research note on Monday, July 23rd. Leerink Swann lowered their price target on Walgreens Boots Alliance from $75.00 to $70.00 and set a “market perform” rating for the company in a research note on Wednesday, May 23rd. ValuEngine cut Walgreens Boots Alliance from a “sell” rating to a “strong sell” rating in a research note on Tuesday, May 22nd. Bank of America cut Walgreens Boots Alliance from a “neutral” rating to an “underperform” rating and lowered their price target for the company from $73.00 to $60.00 in a research note on Thursday, June 28th. Finally, BidaskClub raised Walgreens Boots Alliance from a “buy” rating to a “strong-buy” rating in a research note on Tuesday, August 21st. Two investment analysts have rated the stock with a sell rating, thirteen have issued a hold rating, six have issued a buy rating and one has issued a strong buy rating to the company. The company currently has an average rating of “Hold” and a consensus target price of $77.22.
Walgreens Boots Alliance Profile
Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of general merchandise, including non-prescription drugs, beauty products, photo finishing, seasonal merchandise, greeting cards, and convenience foods through its retail drugstores and convenient care clinics.
Featured Story: Asset Allocation
Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.